Literature DB >> 6644957

Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke.

R L Rogers, J S Meyer, T G Shaw, K F Mortel, J P Hardenberg, R R Zaid.   

Abstract

Effects of chronic cigarette smoking on cerebral blood flow were investigated by measuring gray matter blood flow (Fg) using xenon 133 inhalation among 192 volunteers without cerebrovascular symptoms. There were 108 normal, healthy volunteers; 84 had risk factors for stroke (hypertension, hyperlipidemia, diabetes mellitus, and/or heart disease). Of both risk and nonrisk groups, 75 were habitual smokers (0.5 to 3.5 packs per day for 25 years). Comparisons of mean Fg values for both hemispheres showed significant reductions related to tobacco consumption and risk factors for stroke. Multiple-regression equations using smoking, age, risk, and alcohol consumption indicated a combined R2 value of 0.22. Smoking seems to be a potent risk factor decreasing cerebral blood flow probably by enhancing cerebral arteriosclerosis. Chronic cigarette smoking in persons with other risk factors further reduced Fg values in an additive manner when compared with subjects who had corresponding risk factors who did not smoke.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644957

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  20 in total

1.  Effects of chronic alcohol dependence and chronic cigarette smoking on cerebral perfusion: a preliminary magnetic resonance study.

Authors:  Stefan Gazdzinski; Timothyc Durazzo; Geon-Ho Jahng; Frank Ezekiel; Peter Banys; Dieterj Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2006-06       Impact factor: 3.455

2.  Imaging local cerebral blood flow by Xenon-enhanced computed tomography--technical optimization procedures.

Authors:  J S Meyer; T Shinohara; A Imai; M Kobari; F Sakai; T Hata; W T Oravez; G M Timpe; T Deville; E Solomon
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

3.  Cigarette smoking and cerebral blood flow in a cohort of middle-aged adults.

Authors:  Martine Elbejjani; Reto Auer; Sudipto Dolui; David R Jacobs; Thaddeus Haight; David C Goff; John A Detre; Christos Davatzikos; R Nick Bryan; Lenore J Launer
Journal:  J Cereb Blood Flow Metab       Date:  2018-01-22       Impact factor: 6.200

4.  Use of total cerebral blood flow as an imaging biomarker of known cardiovascular risks.

Authors:  J Richard Jennings; Alicia F Heim; Dora Chieh-Hsin Kuan; Peter J Gianaros; Matthew F Muldoon; Stephen B Manuck
Journal:  Stroke       Date:  2013-07-23       Impact factor: 7.914

Review 5.  Functional brain imaging of tobacco use and dependence.

Authors:  Arthur L Brody
Journal:  J Psychiatr Res       Date:  2005-06-24       Impact factor: 4.791

6.  Smoking, drinking, and other life style factors and cognitive function in men in the Caerphilly cohort.

Authors:  P C Elwood; J E Gallacher; C A Hopkinson; J Pickering; P Rabbitt; B Stollery; C Brayne; F A Huppert; A Bayer
Journal:  J Epidemiol Community Health       Date:  1999-01       Impact factor: 3.710

7.  Secondhand Smoke Exposure and Stroke: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Angela M Malek; Mary Cushman; Daniel T Lackland; George Howard; Leslie A McClure
Journal:  Am J Prev Med       Date:  2015-06-24       Impact factor: 5.043

Review 8.  In vivo brain imaging of human exposure to nicotine and tobacco.

Authors:  Anil Sharma; Arthur L Brody
Journal:  Handb Exp Pharmacol       Date:  2009

9.  Chronic cigarette smoking: implications for neurocognition and brain neurobiology.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff; Sara Jo Nixon
Journal:  Int J Environ Res Public Health       Date:  2010-10-21       Impact factor: 3.390

10.  Smoking status as a potential confound in the BOLD response of patients with schizophrenia.

Authors:  Leonard Leyba; Andrew R Mayer; Randy L Gollub; Nancy C Andreasen; Vincent P Clark
Journal:  Schizophr Res       Date:  2008-08-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.